key: cord-0862137-kjsni90t
authors: Lejay, Anne; Chakfé, Nabil
title: Should we urgently modify the management of SARS-CoV-2 infected patients suffering from acute limb ischemia? Commentary on ‘How does SARS-CoV-2 infection affect survival among patients with cardiovascular emergencies? A cohort study from a German insurance claims database’
date: 2021-03-24
journal: Eur J Vasc Endovasc Surg
DOI: 10.1016/j.ejvs.2021.03.017
sha: c90f04f567fb698c14c7af3ef91df33309585b90
doc_id: 862137
cord_uid: kjsni90t

nan

acute limb ischemia (ALI) 1 . These results are of importance since this study contributes to the search for optimal vascular disease management during the current pandemic.

One of the strengths of this paper is that the authors could compare outcome among infected and non-infected patients in a very large unselected population 1 . The authors therefore showed that morality rates were different among infected and non-infected patients, but interestingly this difference was higher when patients were hospitalized for ALI than when patients were hospitalized for stroke: mortality was 14.3% versus 5% in infected and noninfected patients hospitalized for ALI, while mortality was 12.4% versus 9.0% in infected and non-infected patients hospitalized for stroke. These results support the concept that infection with the SARS-CoV2 virus may lead to a pro-inflammatory and hypercoagulable states that may result in varying types of ischemic events, especially ALI. The pro-inflammatory state might be caused not only by inflammatory cytokines inducing pro-thrombotic state, but it is also evocated that SARS-CoV-2 could directly infect endothelial cells through the angiotensin-converting-enzyme-2 receptor of alveoli, which leads to both endothelial cell activation and dysfunction 2 . Accordingly, ALI in SARS-CoV-2 infected patients presents a novel challenge to practitioners.

The COVID-19 pandemic has in fact drastically altered the medical landscape and forces the practitioners to modify their current clinical practice 3 . The medical and surgical communities had to learn how to manage in hospital patient flows and to select the situations that need to be prioritized depending on the hospital capability and equipment. Todays practice is therefore complex and multifaceted but guidelines the practitioner can refer to, as well as multidisciplinary team practice where all stakeholders are actively engaged will help improve Coordinated efforts are needed to further understand the underlying pathogenesis and to provide optimal treatment strategies 5 .

How does SARS

CoV-2 infection affect survival among patients with cardiovascular emergencies? A cohort study from a German insurance claims database

Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenfe

Learn from the first wave to surf the next one optimally

Editor's choice -European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischemia

The need of research initiatives amidst and after the Covid-19 pandemic: a message from the editors of the EJVES